• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估2015 - 2016年伊朗新生儿苯丙酮尿症筛查项目

Assessing the Phenylketonuria Screening Program in Newborns, Iran 2015-2016.

作者信息

Ganji Foruzan, Naseri Hooshang, Rostampour Noushin, Sedighi Mozhde, Lotfizadeh Masoud

机构信息

Department of Community Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran.

Shahrekord University of Medical Sciences, Shahrekord, Iran.

出版信息

Acta Med Iran. 2018 Jan;56(1):49-55.

PMID:29436795
Abstract

Phenylketonuria is one of the most important congenital disorders and an autosomal recessive metabolic disease that can cause irreversible brain damages, mental retardation, and cognitive disorders if left untreated. In order to reduce the genetic abnormalities caused by this metabolic disease, screening programs are implemented. The quality of the program must be properly assessed to achieve the objectives of this program if promoting children's health is of concern. The descriptive-analytic method is adopted here to assess the phenylketonuria screening program in practice in Chaharmahal and Bakhtiari province since 2012 and analyze the incidence and program coverage. The quality of the screening program is assessed through analyzing the time of diagnosis, beginning of the treatment and the healthcare centers' facilities with checklists. The parental and the staff awareness is assessed through knowledge measuring questionnaires. Cumulative incidence of phenylketonuria in Chaharmahal and Bakhtiari province from 2012 to 2015, is 1 in every 6662 live births. The program coverage across the region is 100%. The recorded on-time sampling index before 5 days of age, indicate 84.6 % in 2015 from 80% in 2012. The treatment begun before the newborn 4 weeks was over in all cases. Program sensitivity was 100 %, and its specificity was 99.9%. Staff awareness is fair with no impact on parental awareness. General quality of the screening program is appropriate, and as to sensitivity and on-time curing specificity, higher staff and parental awareness supervision are recommended as well.

摘要

苯丙酮尿症是最重要的先天性疾病之一,是一种常染色体隐性代谢疾病,如果不进行治疗,会导致不可逆转的脑损伤、智力迟钝和认知障碍。为了减少这种代谢疾病引起的基因异常,实施了筛查项目。如果关注促进儿童健康,就必须对该项目的质量进行适当评估,以实现该项目的目标。本文采用描述性分析方法,对2012年以来恰哈马哈勒-巴赫蒂亚里省实际开展的苯丙酮尿症筛查项目进行评估,并分析发病率和项目覆盖情况。通过使用检查表分析诊断时间、治疗开始时间以及医疗中心的设施来评估筛查项目的质量。通过知识测量问卷评估家长和工作人员的认知情况。2012年至2015年,恰哈马哈勒-巴赫蒂亚里省苯丙酮尿症的累积发病率为每6662例活产中有1例。该项目在整个地区的覆盖率为100%。记录的5日龄前的准时采样指数显示,从2012年的80%上升到了2015年的84.6%。所有病例均在新生儿4周前开始治疗。项目敏感性为100%,特异性为99.9%。工作人员的认知情况尚可,但对家长的认知没有影响。筛查项目的总体质量是合适的,就敏感性和准时治愈特异性而言,建议加强对工作人员和家长认知情况的监督。

相似文献

1
Assessing the Phenylketonuria Screening Program in Newborns, Iran 2015-2016.评估2015 - 2016年伊朗新生儿苯丙酮尿症筛查项目
Acta Med Iran. 2018 Jan;56(1):49-55.
2
[Evolution of the neonatal screening program in the state of Tocantins].[托坎廷斯州新生儿筛查项目的发展历程]
Arq Bras Endocrinol Metabol. 2013 Mar;57(2):112-9. doi: 10.1590/s0004-27302013000200003.
3
Evaluation of effectiveness and outcome of PKU screening and management in the State of Sergipe, Brazil.巴西塞尔希培州苯丙酮尿症筛查与管理的有效性及结果评估。
Arq Bras Endocrinol Metabol. 2014 Feb;58(1):62-7. doi: 10.1590/0004-2730000002885.
4
[Evaluation of the Neonatal Screening Program for congenital hypothyroidism and phenylketonuria in the State of Mato Grosso, Brazil].[巴西马托格罗索州先天性甲状腺功能减退症和苯丙酮尿症新生儿筛查项目评估]
Arq Bras Endocrinol Metabol. 2009 Jun;53(4):446-52. doi: 10.1590/s0004-27302009000400010.
5
Review of neonatal screening programme for phenylketonuria.苯丙酮尿症新生儿筛查项目综述
BMJ. 1991 Aug 10;303(6798):333-5. doi: 10.1136/bmj.303.6798.333.
6
[Program of neonatal screening for phenylketonuria].[苯丙酮尿症新生儿筛查方案]
Rev Chil Pediatr. 1990 Nov-Dec;61(6):309-12.
7
Phenylketonuria detected by the neonatal screening program in Thailand.泰国新生儿筛查项目检测出的苯丙酮尿症。
Southeast Asian J Trop Med Public Health. 2003;34 Suppl 3:179-81.
8
Neonatal screening of phenylketonuria and congenital hypothyroidism in China.中国新生儿苯丙酮尿症和先天性甲状腺功能减退症筛查
Southeast Asian J Trop Med Public Health. 1999;30 Suppl 2:17-9.
9
Past, present and future of newborn screening in Chile.智利新生儿筛查的过去、现在和未来。
J Inherit Metab Dis. 2010 Dec;33 Suppl 3:S301-6. doi: 10.1007/s10545-010-9165-8. Epub 2010 Aug 4.
10
Neonatal screening program in Rajavithi Hospital, Thailand.泰国拉贾维蒂医院的新生儿筛查项目。
Southeast Asian J Trop Med Public Health. 1999;30 Suppl 2:28-32.

引用本文的文献

1
Multiplex Snapshot minisequencing for the detection of common PAH gene mutations in Iranian patients with Phenylketonuria.多重瞬时串联测序法检测伊朗苯丙酮尿症患者常见 PAH 基因突变。
Iran Biomed J. 2023 Jan 1;27(1):46-57. doi: 10.52547/ibj.3856.
2
A policy analysis of the national phenylketonuria screening program in Iran.伊朗全国苯丙酮尿症筛查项目的政策分析
BMC Health Serv Res. 2021 Feb 5;21(1):120. doi: 10.1186/s12913-021-06116-w.
3
Knowledge about Neonatal Screening among Postpartum Women and Complexity Level of Birthing Facilities.
产后女性对新生儿筛查的认知及分娩机构的复杂程度
Int J Neonatal Screen. 2019 Jan 22;5(1):8. doi: 10.3390/ijns5010008. eCollection 2019 Mar.
4
Phenylketonuria screening in Iranian newborns: a systematic review and meta-analysis.伊朗新生儿苯丙酮尿症筛查:系统评价和荟萃分析。
BMC Pediatr. 2020 Jul 24;20(1):352. doi: 10.1186/s12887-020-02230-6.